ASM
ESLAW icon

ATW SPAC Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

ATW SPAC Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-183,099
Closed -$10.6K – 167
2024
Q2 		$10.6K Hold
183,099
– – 0.01% 114
2024
Q1 		$9.42K Hold
183,099
– – 0.01% 122
2023
Q4 		$5.49K Buy
+183,099
New +$14.3K 0.01% 134

Other funds holding ESLAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

ATW SPAC Management's ESLAW Position: Q3 2025 in Review

ATW SPAC Management held its Estrella Immunopharma Warrant (ESLAW) position steady in Q3 2025 at 183,099 shares worth $9.48K. The position accounts for 0.01% of the portfolio, ranked #127.

ATW SPAC Management first reported a position in ESLAW in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.93M in Q4 2021. 12 funds tracked by Wall St. Rank hold ESLAW as of Q3 2025.

  • ATW SPAC Management held 183,099 shares of Estrella Immunopharma Warrant worth $9.48K as of Q3 2025.
  • ATW SPAC Management left its Estrella Immunopharma Warrant share count unchanged in Q3 2025.
  • Estrella Immunopharma Warrant made up 0.01% of ATW SPAC Management's portfolio in Q3 2025, its #127 holding.
  • ATW SPAC Management first reported a position in Estrella Immunopharma Warrant in Q3 2021 and has held it in 14 quarters since.
  • ATW SPAC Management's Estrella Immunopharma Warrant position peaked at $1.93M in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q3 2025.

Based on ATW SPAC Management's 13F filing for Q3 2025, filed 12 Nov 2025.